DocGo to Release Q4 and Full Year 2025 Financial Results and Host Conference Call

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: Mar 02 2026

0mins

DCGO+0.62%

Should l Buy DCGO?

Source: Newsfilter

Earnings Release Schedule: DocGo will announce its financial results for Q4 and the full year 2025 after market close on March 16, 2025, reflecting the company's commitment to transparency and investor communication.
Conference Call Details: Management will host a conference call at 5:00 p.m. ET on the same day to discuss financial results and outlook for 2026, which is expected to attract investor interest and bolster market confidence.
Tech-Enabled Healthcare Services: DocGo is reshaping the traditional healthcare system through its innovative medical transportation and mobile health services platform, providing high-quality and accessible care to meet patients' immediate needs.
Investor Relations Platform: The company's website offers a webcast of the conference call, enhancing interaction with investors and further improving the company's transparency and trustworthiness in the healthcare sector.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy DCGO?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on DCGO

Wall Street analysts forecast DCGO stock price to rise

4 Analyst Rating

3 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.645

Low

1.50

Averages

3.13

High

4.00

Current: 0.645

Low

1.50

Averages

3.13

High

4.00

Canaccord

Hold

downgrade

2025-11-12

Reason

Canaccord

Price Target

AI Analysis

2025-11-12

downgrade

Hold

Reason

Canaccord lowered the firm's price target on DocGo to $1.50 from $1.60 and keeps a Hold rating on the shares. The firm said while the price target does portend upside from current levels they believe that there is some value to be had for DocGo operations however, they do not see multiple expansion from a fundamental perspective until there is meaningful adj-EBITDA loss improvement.

Canaccord

Richard Close

Hold

maintain

2025-08-21

Reason

Canaccord

Richard Close

Price Target

2025-08-21

maintain

Hold

Reason

Canaccord analyst Richard Close raised the firm's price target on DocGo to $1.60 from $1.45 and keeps a Hold rating on the shares. The firm said DocGo showed some progress with its core business in 2Q as it works to replace the waning migrant services contract(s) that should be largely wound down entering 2H;however, there is much work to be done to rightsize the organization while also ramping up new business.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for DCGO

Unlock Now

About DCGO

DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

DocGo to Release Q4 and Full Year 2025 Financial Results on March 16, 2025

Mar 02 2026Businesswire

Earnings Release Schedule: DocGo will announce its fourth quarter and full year financial results for the period ending December 31, 2025, after market close on March 16, 2025, highlighting the company's performance in medical transportation and mobile health services.
Conference Call Details: Management will host a conference call at 5:00 p.m. ET on the same day to discuss the financial results and outlook for 2026, which is expected to attract investor and analyst attention, enhancing the company's transparency.
Innovative Healthcare Platform: DocGo's technology-enabled medical transportation and mobile health services aim to reshape the traditional healthcare system by providing high-quality, accessible care that enhances patient experience and strengthens market competitiveness.
Telehealth Integration: DocGo's mobile health services facilitate patient treatment in collaboration with remote physicians, enabling care in the comfort of patients' homes or workplaces, and seamlessly bridging physical and virtual care through its medical transport services, thereby improving overall healthcare efficiency.